Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-κB

被引:328
作者
Langen, RCJ
Schols, AMWJ
Kelders, MCJM
Wouters, EFM
Janssen-Heininger, MW
机构
[1] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA
[2] Maastricht Univ, Dept Pulmonol, Maastricht, Netherlands
关键词
cachexia; muscle wasting; TNF-alpha; NF-kappa B; myogenic differentiation;
D O I
10.1096/fj.00-0463
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Muscle wasting is often associated with chronic inflammation, Because tumor necrosis factor alpha (TNF-alpha) has been implicated as a major mediator of cachexia, its effects on C2C12 myocytes were examined, TNF-alpha activated nuclear factor-kappaB (NF-kappaB) and interfered with the expression of muscle proteins in differentiating myoblasts, Introduction of a mutant form of inhibitory protein kappaB alpha (I kappaB alpha) restored myogenic differentiation in myoblasts treated with TNF-alpha or interleukin 1 beta, Conversely, activation of NF-kappaB by overexpression of I kappaB kinase was sufficient to block myogenesis, illustrating the causal link between NF-kappaB activation and inhibition of myogenic differentiation. The inhibitory effects of TNF-alpha on myogenic differentiation were reversible, indicating that the effects of the cytokine were not due to nonspecific toxicity, Treatment of differentiated myotubes with TNF-alpha did not result in a striking loss of muscle-specific proteins, which shows that myogenesis was selectively affected in the myoblast stage by TNF-alpha, An important finding was that NF-kappaB was activated to the same extent in differentiating and differentiated cells, illustrating that once myocytes have differentiated they become refractory to the effects of NF-kappaB activation, These results demonstrate that inflammatory cytokines may contribute to muscle wasting through the inhibition of myogenic differentiation via a NF-kappaB-dependent pathway.
引用
收藏
页码:1169 / 1180
页数:12
相关论文
共 55 条
  • [1] Wasting as independent risk factor for mortality in chronic heart failure
    Anker, SD
    Ponikowski, P
    Varney, S
    Chua, TP
    Clark, AL
    WebbPeploe, KM
    Harrington, D
    Kox, WJ
    PooleWilson, PA
    Coats, AJS
    [J]. LANCET, 1997, 349 (9058) : 1050 - 1053
  • [2] Anker SD, 1997, LANCET, V349, P1258
  • [3] Argiles JM, 1999, MED RES REV, V19, P223, DOI 10.1002/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.0.CO
  • [4] 2-N
  • [5] BELEC L, 1995, J ACQ IMMUN DEF SYND, V8, P212
  • [6] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [7] Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants
    Buck, M
    Chojkier, M
    [J]. EMBO JOURNAL, 1996, 15 (08) : 1753 - 1765
  • [8] INTERLEUKIN-1 RECEPTOR ANTAGONIST PREVENTS SEPSIS-INDUCED INHIBITION OF PROTEIN-SYNTHESIS
    COONEY, R
    OWENS, E
    JURASINSKI, C
    GRAY, K
    VANNICE, J
    VARY, T
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1994, 267 (05): : E636 - E641
  • [9] CORNELIUS P, 1991, J BIOL CHEM, V266, P4023
  • [10] CORNELIUS P, 1990, J BIOL CHEM, V265, P20506